Turnover of human villous trophoblast in normal pregnancy: What do we know and what do we need to know?

被引:80
作者
Mayhew, T. M. [1 ]
机构
[1] Univ Nottingham, Queens Med Ctr, Sch Life Sci, Nottingham NG7 2UH, England
关键词
Villous trophoblast; Proliferation; Differentiation; Turnover; Deportation; INTRAUTERINE GROWTH RESTRICTION; HUMAN PLACENTAL VILLI; SYNCYTIAL KNOTS; FETOPLACENTAL ANGIOGENESIS; TRANSCRIPTIONAL-ACTIVITY; MATERNAL CIRCULATION; INCREASED APOPTOSIS; OXIDATIVE STRESS; CELL TURNOVER; EXPRESSION;
D O I
10.1016/j.placenta.2014.01.011
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
How the turnover of villous trophoblast is regulated is important for understanding normal and complicated pregnancies. There is considerable accord that syncytiotrophoblast (STB) grows and is refreshed by recruiting post-mitotic cells from the deeper cytotrophoblast (CTB). Nuclei in SIB exhibit a spectrum of morphologies and packing densities and, until recently, there seemed to be a consensus that this variation reflected a transition from an early undifferentiated CTB-like phenotype to a long pre-apoptotic and brief apoptotic phase. In these later phases, nuclei are sequestered in clusters (syncytial knots) prior to extrusion as part of normal epithelial turnover. Early in gestation, nuclear clustering and formation of protrusions (syncytial sprouts) also occurs as a preliminary to villous sprouting. Nuclei in these clusters have a CTB-like phenotype and some sprouts may also detach from STB and pass into the uteroplacental circulation. However, this apparent consensus has been challenged and new interpretations of events in the proliferative (CTB), terminal differentiation (STB) and deportation compartments have emerged. Several different types of STB fragment are deported in normal pregnancy: larger multinucleate STB fragments, smaller uninucleate elements with CTB-like morphology, anucleate cytoplasmic fragments, microparticles and nanovesicles. This review identifies points of agreement and disagreement and offers possible avenues of future research. An obvious need is to standardise best practice in several areas including choosing appropriate references for cell cycle phase labelling indices and combining immunolabeling of cell cycle and apoptosis markers (at LM or TEM levels) with design-based stereological estimates of absolute numbers of cells and nuclei in different compartments throughout normal gestation. This would also provide a surer foundation for interpreting results from different research groups and changes in normal and complicated pregnancies. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:229 / 240
页数:12
相关论文
共 50 条
  • [1] Genetic platforms: Do we do what we know? or do we know what we do?
    Bernet, Laia
    Pla, Maria Jesus
    Janez, Noelia Martinez
    REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2021, 34 (02): : 100 - 110
  • [2] Cognitive Effects of Cancer and Its Treatments at the Intersection of Aging: What Do We Know; What Do We Need to Know?
    Mandelblatt, Jeanne S.
    Hurria, Arti
    McDonald, Brenna C.
    Saykin, Andrew J.
    Stern, Robert A.
    Van Meter, John W.
    McGuckin, Meghan
    Traina, Tiffani
    Denduluri, Neelima
    Turner, Scott
    Howard, Darlene
    Jacobsen, Paul B.
    Ahles, Tim
    SEMINARS IN ONCOLOGY, 2013, 40 (06) : 709 - 725
  • [3] Vaginal Aging-What We Know and What We Do Not Know
    Szymanski, Jacek K.
    Slabuszewska-Jozwiak, Aneta
    Jakiel, Grzegorz
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (09)
  • [4] β Cell and Autophagy: What Do We Know?
    Mohammadi-Motlagh, Hamid-Reza
    Sadeghalvad, Mona
    Yavari, Niloofar
    Primavera, Rosita
    Soltani, Setareh
    Chetty, Shashank
    Ganguly, Abantika
    Regmi, Shobha
    Floyel, Tina
    Kaur, Simranjeet
    Mirza, Aashiq H. H.
    Thakor, Avnesh S. S.
    Pociot, Flemming
    Yarani, Reza
    BIOMOLECULES, 2023, 13 (04)
  • [5] Schistosomiasis and Infertility: What Do We Know?
    Ribeiro, Ana Rita
    Luis, Carla
    Fernandes, Ruben
    Botelho, Monica C.
    TRENDS IN PARASITOLOGY, 2019, 35 (12) : 964 - 971
  • [6] Merkel cell carcinoma: What do we know about it and what should we do?
    Prieto Munoz, Isabel
    Pardo Masferrer, Jose
    Olivera Vegas, Jesus
    Fortes Alen, Jose Ramon
    Perez Casas, Ana M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (06) : 401 - 412
  • [7] Fibromyalgia and nutrition, what do we know?
    Arranz, Laura-Isabel
    Canela, Miguel-Angel
    Rafecas, Magda
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (11) : 1417 - 1427
  • [8] Big Tau: What We Know, and We Need to Know
    Fischer, Itzhak
    ENEURO, 2023, 10 (05)
  • [9] Outstanding Questions in Mitophagy: What We Do and Do Not Know
    Montava-Garriga, Lambert
    Ganley, Ian G.
    JOURNAL OF MOLECULAR BIOLOGY, 2020, 432 (01) : 206 - 230
  • [10] The side effects of phototherapy for neonatal jaundice: what do we know? What should we do?
    Xiong, Tao
    Qu, Yi
    Cambier, Stephanie
    Mu, Dezhi
    EUROPEAN JOURNAL OF PEDIATRICS, 2011, 170 (10) : 1247 - 1255